TAG:
diagnostic testing
Oncology’s Potential Drives AP Lab Expansion
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
Sysmex Anticipates Major Shifts In Laboratory Testing Market
“Innovating from our core technologies will lead Sysmex into very different areas of laboratory testing.” —John Kershaw CEO SUMMARY: Sysmex America, Inc. surprised many this year when it hired its own sales and service team and begin distribu…
Molecular Diagnostics’ “Gap in Expectations”
CEO SUMMARY: This year’s Executive War College provided strong evidence that the twin trends of molecular diagnostics and Lean management methods are taking root within the laboratory industry. Each is a trend in its infancy. Molecular diagnostics will require considerable time before i…
Pathologist Activities Evolve In VA’s “Paperless” Hospitals
“When a hospital or laboratory goes ‘paperless’, it’s no longer ‘business as usual’ for pathologists.” —Bruce Dunn, M.D. CEO SUMMARY: One outcome of the Veteran Administration’s (VA) ongoing effort to create a totally-integrated i…
“June 7, 2004 Intelligence: Late Breaking Lab News”
Business Week Magazine placed Bio-Reference Laboratories, Inc. (BRLI) on its 2004 list of the Top 100 Hot Growth Stocks. BRLI, based in Elmwood Park, New Jersey, was ranked 16th. Business Week announced the list in its June 7, 2004 issue. With steady growth in reven…
Beckman Loses Auction To Buy Lab-InterLink
CEO SUMMARY: For laboratories with automation equipment from Lab-InterLink, the sale of the troubled company to Cardinal Health is good news. At the same time, interesting questions are triggered by this development. What plans does Cardinal Health have for the laboratory testing marketpl…
New Esoteric Lab Firm Does Two Acquisitions
CEO SUMMARY: Armed with $70 million, American Esoteric Laboratories (AEL) wants to build a national laboratory that offers a full menu of esoteric tests. It is building a primary laboratory in Dallas, which has one of the nation’s best air transport hubs. ThromboCare Laboratories and Vi…
LabCorp Buys MDS Labs In New York and Georgia
CEO SUMMARY: It’s the final chapter of the “Canadian Invasion” of the U.S. laboratory testing market. In the mid-1990s, both MDS and Dynacare built a sizeable presence in the United States as they both worked to develop joint ventures with hospital laboratories. Dynacare was acquire…
Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.
EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per …
Oncology Diagnostics Attracts Big Money
MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition of IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the …
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.